We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Phreesia (PHR - Free Report) to post quarterly loss of $0.51 per share in its upcoming report, which indicates a year-over-year increase of 27.1%. Revenues are expected to be $101.01 million, up 20.5% from the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Phreesia metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Revenus- Subscription and related services' should come in at $46.95 million. The estimate indicates a change of +23.9% from the prior-year quarter.
The average prediction of analysts places 'Revenus- Network solutions' at $26.04 million. The estimate indicates a change of +20% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenus- Payment processing fees' of $27.92 million. The estimate indicates a change of +15.1% from the prior-year quarter.
The consensus estimate for 'Average healthcare services Clients' stands at 4,068. The estimate is in contrast to the year-ago figure of 3,309.
It is projected by analysts that the 'Patient payment volume' will reach $1.20 billion. The estimate is in contrast to the year-ago figure of $1.02 billion.
Analysts' assessment points toward 'Average revenue per healthcare services client' reaching $18.51 million. Compared to the current estimate, the company reported $18.78 million in the same quarter of the previous year.
Phreesia shares have witnessed a change of +9.8% in the past month, in contrast to the Zacks S&P 500 composite's +4% move. With a Zacks Rank #3 (Hold), PHR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics
Wall Street analysts expect Phreesia (PHR - Free Report) to post quarterly loss of $0.51 per share in its upcoming report, which indicates a year-over-year increase of 27.1%. Revenues are expected to be $101.01 million, up 20.5% from the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Phreesia metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Revenus- Subscription and related services' should come in at $46.95 million. The estimate indicates a change of +23.9% from the prior-year quarter.
The average prediction of analysts places 'Revenus- Network solutions' at $26.04 million. The estimate indicates a change of +20% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenus- Payment processing fees' of $27.92 million. The estimate indicates a change of +15.1% from the prior-year quarter.
The consensus estimate for 'Average healthcare services Clients' stands at 4,068. The estimate is in contrast to the year-ago figure of 3,309.
It is projected by analysts that the 'Patient payment volume' will reach $1.20 billion. The estimate is in contrast to the year-ago figure of $1.02 billion.
Analysts' assessment points toward 'Average revenue per healthcare services client' reaching $18.51 million. Compared to the current estimate, the company reported $18.78 million in the same quarter of the previous year.
View all Key Company Metrics for Phreesia here>>>
Phreesia shares have witnessed a change of +9.8% in the past month, in contrast to the Zacks S&P 500 composite's +4% move. With a Zacks Rank #3 (Hold), PHR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>